A Drug-Drug Interaction Study in Healthy Volunteers of the Effects of Tucatinib on Metformin

Clinical trial NCT03826602 · COMPLETED

Trial details

NCT number: NCT03826602
Sponsor: Seagen Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Drug-drug Interaction

Start date: 2019-02-12
Primary completion: 2019-03-08
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.